YD Bio (YDES) Liabilities and Shareholders Equity (2024 - 2026)
YD Bio's (YDES) quarterly Liabilities and Shareholders Equity came in at $10.1 million in Q2 2026, up 72.23% year-over-year from $5.8 million in Q2 2025, and down 26.99% quarter-over-quarter from $13.8 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $10.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 72.23% year-over-year to $10.1 million in Q2 2026; TTM through Jun 2026 was $36.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $13.8 million, up 100.74% from the prior year.
- Liabilities and Shareholders Equity was $10.1 million for Q2 2026 at YD Bio, down from $13.8 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $13.8 million in Q4 2025 and troughed at $5.8 million in Q2 2025.
- A 3-year average of $9.1 million and a median of $8.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity surged 100.74% in 2025 and surged 72.23% in 2026, its largest moves.
- Over 3 years, Liabilities and Shareholders Equity stood at $6.9 million in 2024, then surged by 100.74% to $13.8 million in 2025, then declined by 26.99% to $10.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $10.1 million (Q2 2026), $13.8 million (Q4 2025), and $5.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 10.96 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 10.03 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 5.31 Bn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 10.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.06 Mn |
| Dec 31, 2025 | 13.78 Mn |
| Jun 30, 2025 | 5.84 Mn |
| Dec 31, 2024 | 6.86 Mn |
API Access
YD Bio Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();